ETFs
D
RDY
Dr Reddys Labs
12.19
0.000.00%Closed17:19 09/18 EDT
OPEN/PREV CLOSE12.18/12.19
TODAY RANGE12.14-12.26
VOL1.89M
MARKET CAP10.15B
52 WEEK RANGE11.28-15.56
AVG VOL (3M)2.92M
% TURNOVER0.23%
TURNOVER--
P/E (TTM)28.95
% RANGE1.03%
EPS(TTM)0.4211
P/E(FORWARD)25.25
P/B2.498
BVPS4.879
DIVIDEND0.0834
P/S2.824
BETA--
DIV YIELD0.68%
FREE FLOAT MKT CAP10.15B
SHARES OUTSTANDING832.99M
NEXT EARNINGS10/22-10/26
FREE FLOAT832.74M
LOT SIZE1
EX-DATE07/24/2026
News
Press Releases
Financial Reports
Profile
Benzinga·4d ago
Dr Reddy's Laboratories Q1 2027 Earnings Call Transcript
TipRanks·09/11 12:15
Immutep provides update on development strategy for eftilagimod alfa
TipRanks·09/10 15:56
Dr. Reddy’s Issues New ESOP Shares After ADR Option Exercise
TipRanks·09/10 15:56
Dr. Reddy’s Schedules September Analyst and Investor Meetings
Seeking Alpha·09/01 14:05
Highest and lowest quant-rated healthcare stocks above $10B cap after earnings season
TipRanks·08/26 18:27
Dr. Reddy’s Laboratories Allots New Shares Under Employee Stock Option Scheme
TipRanks·08/24 16:30
RDY Backs Keytruda Biosimilar Trial in Melanoma: What Investors Should Watch
TipRanks·08/17 11:17
Dr. Reddy’s Receives USFDA Form 483 for Bachupally Plant After August Inspection
TipRanks·08/16 12:49
Dr. Reddy’s says FDA inspection of UK facility ‘officially closed’
TipRanks·08/13 14:17
Dr. Reddy’s Announces Resignation of API and Services CEO Deepak Sapra